Agenda Topics- Diagnostics Regulatory Updates
- Imaging Based Diagnostics
- Intellectual Property, Reimbursement & HTA Focus
- NGS-Based Diagnostics
- Personalised Breast Cancer Medicine
- Whole Genome Sequencing, The 100,000 Project
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Distinguished FacultyIain Miller, Co-Founder, Healthcare Strategies Group Claudia Meinken, European Patent Attorney, Patents and Trademarks for Life Sciences Christoph Turck, Head, Max Planck Institute of Psychiatry Jurgen Eils, Head, German Cancer Research Centre Charles Cox, Head Genetics Experiment Design and Delivery, GSK Pharmaceuticals Thomas Krahn, Head of Global Biomarker Research Department, Bayer Pharma Ag Cecilia Schott, Head Personalized Healthcare, Corporate Business Development Global Product & Portfolio Strategy, AstraZeneca Kristin Ciriello Pothier, Partner & Managing Director/Life Sciences Leader, Ernst and Young LLP James Brenton, Senior Group Leader, Cancer Research UK Rosalind Polley, Senior Medical Device Specialist, Medicines & Healthcare Products Regulatory Agency (MHRA) Andreas Schuppert, Vice President, Bayer Technology Services GmbH
|